Table 1.
Summary of pairwise comparisons between disease groups.
| I. CXC chemokines |
| A. Neutrophil chemoattractants |
| • Growth-related oncogene (GRO)-α/CXCL1 |
| BD > VKH, sarcoidosis |
| HLA-B27 > VKH, sarcoidosis |
| • GRO-β/CXCL2 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • Epithelial-derived neutrophil attractant-78 (ENA-78)/CXCL5 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • Granulocyte chemotactic protein-2 (GCP-2)/CXCL6 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • Interleukin-8 (IL-8)/CXCL8 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| B. T helper-1 (Th1) lymphocyte chemoattractants |
| Interferon-γ-inducible protein of 10 kDa (IP-10)/CXCL10 |
| BD >VKH |
| C. Lymphoid chemokines |
| B cell attracting chemokine-1 (BCA-1)/CXCL13 |
| VKH, sarcoidosis > BD |
| VKH > HLA-B27 |
| II. Soluble form of transmembrane chemokines (Preferentially act on Th1 lymphocytes) |
| • Scavenger receptor for phosphatidyl serine and oxidized low-density lipoprotein |
| (SR-PSOX)/CXCL16 |
| BD > VKH, sarcoidosis |
| HLA-B27 > VKH, sarcoidosis |
| • Fractalkine/CX3CL1 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| Sarcoidosis > VKH |
| III. CC chemokines |
| • Monocyte chemotactic protein (MCP)-1/CCL2 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • MCP-3/CCL7 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • MCP-2/CCL8 |
| BD, HLA-B27 > sarcoidosis |
| HLA-B27 > VKH |
| • MCP-4/CCL13 |
| HLA-B27 > VKH, sarcoidosis |
| • Thymus- and activation-related chemokine (TARC)/CCL17 |
| HLA-B27 > VKH |
| • Macrophage inflammatory protein (MIP)-3α/CCL20 |
| BD > VKH |
| HLA-B27 > BD, VKH, sarcoidosis |
| • Thymus-expressed chemokine (TECK)/CCL25 |
| HLA-B27 > VKH, sarcoidosis |
| • Eotaxin-3/CCL26 |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| IV. Cytokines and soluble cytokine receptors |
| • Interferon-γ |
| BD > VKH |
| HLA-B27 > VKH, sarcoidosis |
| • Tumor necrosis factor-α (TNF-α) |
| HLA-B27 > VKH |
| • Interleukin (IL)-1β |
| BD > VKH |
| HLA-B27 > BD, VKH, sarcoidosis |
| • IL-6 |
| BD > VKH, sarcoidosis |
| HLA-B27 > VKH, sarcoidosis |
| • IL-11 |
| HLA-B27 > VKH, sarcoidosis |
| • IL-12p40 |
| BD > VKH |
| HLA-B27 > VKH |
| • IL-19 |
| HLA-B27 > BD, VKH, sarcoidosis |
| • IL-35 |
| HLA-B27 > VKH |
| • Granulocyte-macrophage colony-stimulating factor (GM-CSF) |
| HLA-B27 > VKH, sarcoidosis |
| • The TNF-like weak inducer of apoptosis (TWEAK) |
| VKH > HLA-B27 |
| Sarcoidosis > BD, HLA-B27 |
| • Soluble (s) CD30 |
| VKH > BD, HLA-B27 |
BD, Behçet's disease; HLA-B27, HLA-B27-associated uveitis; VKH, Vogt-Koyanagi-Harada disease.